True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
"cd8-positive, alpha-beta t cell",Cytotoxic Lymphocyte,"Cytotoxic Gamma-Delta (γδ) T Cells, Cytotoxic CD8+ Alpha-Beta (αβ) T Cells, Natural Killer (NK) Cells",,50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will meticulously analyze this list of highly expressed markers from a single-cell cluster derived from human large intestine tissue to identify its cell type. I will follow the prescribed step-by-step approach to provide a comprehensive and specific annotation. **Input Marker List (ranked by expression intensity, high to low):** KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2 --- **1. List the Key Functional Markers:** These markers are indicative of specific cellular functions, particularly immune responses, cytotoxicity, and cytokine signaling. * **Cytotoxicity/Granzyme Family:** * **GZMH, GZMA, GZMB, GZMK, GZMM:** These are Granzymes, serine proteases primarily found in the granules of cytotoxic T lymphocytes (CTLs) and Natural Killer (NK) cells. They induce apoptosis in target cells. Their high expression is a strong indicator of cytotoxic activity. * **PRF1 (Perforin 1):** A pore-forming protein released by CTLs and NK cells. It creates pores in the target cell membrane, allowing granzymes to enter and induce apoptosis. Co-expression with granzymes is a hallmark of cytotoxic cells. * **NKG7:** A transmembrane protein found in the granules of NK cells and CTLs, involved in granule exocytosis and cytotoxic function. * **CTSW (Cathepsin W):** A cysteine protease found in cytotoxic lymphocytes, potentially involved in processing granzymes or other granule components. * **CST7 (Cystatin F):** A cysteine protease inhibitor, often co-expressed with cytotoxic markers, potentially involved in regulating protease activity. * **Chemokines/Cytokines and Receptors:** * **XCL2, XCL1 (X-C motif chemokine ligand 2/1):** Chemokines primarily produced by NK cells and cytotoxic T cells, involved in recruiting immune cells. * **CCL4, CCL4L2, CCL5 (Chemokine (C-C motif) ligand 4/4-like 2/5):** Potent chemokines involved in recruiting various immune cells, including T cells, NK cells, and monocytes, to sites of inflammation. High expression indicates an active immune response. * **IFNG (Interferon Gamma):** A crucial cytokine produced by NK cells and T cells, particularly Th1 and cytotoxic T cells. It plays a central role in antiviral and antitumor immunity, activating macrophages and enhancing MHC expression. * **IL21R (Interleukin 21 Receptor):** Receptor for IL-21, a cytokine that promotes the differentiation and function of NK cells and cytotoxic T cells. Its presence suggests responsiveness to IL-21 signaling. * **Inhibitory/Co-inhibitory Receptors:** * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on T cells and NK cells, involved in immune checkpoint regulation. Its presence suggests potential modulation of immune responses. * **LAG3 (Lymphocyte-activation gene 3):** An inhibitory receptor expressed on activated T cells and NK cells, another immune checkpoint molecule. * **CD160:** An inhibitory receptor expressed on NK cells and some T cells, particularly cytotoxic T cells. * **Activation/Co-stimulatory Markers:** * **TNFRSF9 (CD137/4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, promoting their proliferation and survival. Its presence suggests an activated state. --- **2. List the Key Cell Type Markers:** These markers are highly specific to particular immune cell lineages, especially those involved in cytotoxic functions. * **Natural Killer (NK) Cell Markers:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2D ligand), KLRD1 (CD94):** These are Killer Cell Lectin-like Receptors, characteristic markers of NK cells. NKG2C and NKG2D are activating receptors, while CD94 often pairs with NKG2A (an inhibitory receptor, though not highly expressed here) or NKG2C. Their strong presence is a definitive indicator of NK cell lineage. * **CD160:** While also an inhibitory receptor, it is highly expressed on NK cells. * **XCL1, XCL2:** As noted above, these chemokines are highly characteristic of NK cells. * **GPR18:** A G protein-coupled receptor, also known as the 'cannabinoid receptor 2' or 'N-arachidonylglycine receptor,' expressed on various immune cells, including NK cells. * **CRTAM (Class I-restricted T cell-associated molecule):** Expressed on NK cells and some T cells, involved in cell-cell adhesion and activation. * **Cytotoxic T Lymphocyte (CTL) Markers:** * **CD8B, CD8A:** Components of the CD8 co-receptor, a defining marker for cytotoxic T lymphocytes (CTLs). CD8+ T cells recognize antigens presented by MHC class I molecules. Their co-expression with granzymes and perforin is a strong indicator of CTLs. * **TRGC2, TRGC1 (T cell receptor gamma constant 2/1):** These are components of the T cell receptor (TCR) gamma chain, indicating a T cell lineage. Specifically, the presence of TRGC1 and TRGC2 points towards Gamma-Delta (γδ) T cells, which are a distinct T cell subset. * **CD7:** A pan-T cell marker, also found on NK cells. * **SH2D1A (SAP):** Signaling lymphocyte activation molecule associated protein, critical for NK cell and T cell function, particularly NKT cells and cytotoxic T cells. Mutations cause X-linked lymphoproliferative syndrome. * **General Lymphocyte/Immune Markers:** * **LINC02446:** A long intergenic non-coding RNA. Its specific role in cell type identification is less established compared to protein-coding genes, but its high expression suggests a functional role within this specific cell type. * **SLA2:** Signaling lymphocyte activation molecule family member 2. Involved in immune cell activation and adhesion. * **ABI3:** Actin-binding protein involved in cell motility and signaling, expressed in immune cells. * **PTPN22:** Protein tyrosine phosphatase non-receptor type 22, involved in regulating T cell activation. * **ZEB2:** Zinc finger E-box binding homeobox 2, a transcription factor involved in various developmental processes and immune cell differentiation. * **HOPX:** Homeodomain-only protein homeobox, a transcription factor with roles in cell differentiation and proliferation, also found in some immune cells. * **LAYN:** Layilin, a hyaluronan receptor, expressed on some immune cells. * **IKZF2 (Helios):** A transcription factor, part of the Ikaros family, expressed in regulatory T cells and some activated T cells. --- **3. Cross-reference Known Databases:** A quick mental cross-reference with common scRNA-seq atlases (e.g., Human Cell Atlas, Tabula Sapiens, specific gut immunity datasets) and marker databases (e.g., CellMarker, PanglaoDB, ImmGen) strongly supports the initial assessment. * **NK Cell Markers:** KLRC2, KLRK1, KLRC4, KLRD1, CD160, XCL1, XCL2, NKG7 are canonical NK cell markers. * **Cytotoxic T Cell Markers:** CD8A, CD8B, GZMA, GZMB, GZMH, GZMK, PRF1, NKG7, IFNG, CCL4, CCL5 are canonical cytotoxic T cell markers. * **Gamma-Delta T Cell Markers:** The presence of TRGC1 and TRGC2, alongside cytotoxic markers, is highly suggestive of γδ T cells. These cells often express NK cell receptors and exhibit cytotoxic functions. * **Overlap:** The significant overlap in cytotoxic machinery (granzymes, perforin, NKG7) and chemokine production (XCL1, XCL2, CCL4, CCL5, IFNG) between NK cells and cytotoxic T cells (both αβ and γδ) is evident. The key to differentiation lies in the specific lineage markers. --- **4. Determine the Most Probable General Cell Type:** The overwhelming presence of genes associated with cytotoxicity (Granzymes, Perforin, NKG7), T cell receptors (CD8A/B, TRGC1/2), and NK cell receptors (KLRC2, KLRK1, KLRC4, KLRD1) points unequivocally to a **Cytotoxic Lymphocyte** population. These are immune cells specialized in killing infected or cancerous cells. --- **5. Identify the Top 3 Most Probable Sub Cell Types:** Based on the specific markers, I can infer the following: 1. **Most Likely: Cytotoxic Gamma-Delta (γδ) T Cells:** * **Strong Evidence:** The co-expression of **TRGC1** and **TRGC2** (gamma-delta TCR constant regions) is the most definitive marker for γδ T cells. * **Supporting Evidence:** These cells frequently express **CD8A/B** (though they can also be CD4-CD8- or CD4+), and crucially, they often express a wide array of **NK cell receptors (KLRC2, KLRK1, KLRC4, KLRD1, CD160)** and exhibit potent cytotoxic functions (high expression of **GZMA, GZMB, GZMH, GZMK, PRF1, NKG7**). They are also known to produce **IFNG, XCL1, XCL2, CCL4, CCL5**. The presence of **TIGIT** and **LAG3** is also consistent with activated T cells, including γδ T cells. In the large intestine, γδ T cells are abundant and play critical roles in immune surveillance and tissue homeostasis, often acting as first responders and exhibiting NK-like functions. 2. **Second Most Likely: Cytotoxic CD8+ Alpha-Beta (αβ) T Cells:** * **Strong Evidence:** High expression of **CD8A** and **CD8B** is a hallmark of cytotoxic T lymphocytes. * **Supporting Evidence:** The presence of a full suite of cytotoxic effector molecules (**GZMA, GZMB, GZMH, GZMK, PRF1, NKG7, CTSW**), pro-inflammatory cytokines/chemokines (**IFNG, CCL4, CCL5, XCL1, XCL2**), and activation markers (**TNFRSF9, TIGIT, LAG3**) is highly characteristic of activated CD8+ CTLs. * **Distinguishing Factor from γδ T cells:** While CD8+ αβ T cells are a strong candidate, the explicit presence of **TRGC1/TRGC2** (gamma-delta TCR) makes γδ T cells a more specific and likely annotation for this particular cluster, as αβ T cells would express TRAC/TRBC (alpha-beta TCR constant regions) which are not listed. 3. **Third Most Likely: Natural Killer (NK) Cells:** * **Strong Evidence:** The high expression of numerous NK cell-specific receptors (**KLRC2, KLRK1, KLRC4, KLRD1, CD160, CRTAM**) is a clear indicator of NK cell lineage. * **Supporting Evidence:** NK... [truncated]"
intestinal crypt stem cell,Intestinal Stem Cells,"LGR5+ Crypt Base Columnar (CBC) Stem Cells, Early Intestinal Progenitor Cells (Transit-Amplifying Cells), Secretory Progenitor Cells (e.g., immature Goblet/Paneth/Enteroendocrine cells)",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: This is an excellent challenge. Let's break down this marker list to precisely identify the cell type from human large intestine tissue. **Analysis of Provided Marker List:** The provided list contains a mix of protein-coding genes, pseudogenes (indicated by 'P' in their names, e.g., RPL7P54, HMGN2P6), and uncharacterized loci (e.g., AL031284.1, AC012085.1). For cell type annotation, we will primarily focus on the well-characterized protein-coding genes with known biological functions. Pseudogenes and uncharacterized loci, while present in the transcriptome, are generally less informative for direct cell type identification unless they are specifically known to be highly expressed or regulated in a particular cell type. **Step 1. List the Key Functional Markers:** From the provided list, the most prominent functional markers are: * **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is a canonical and highly specific marker for actively cycling intestinal stem cells. LGR5+ cells are multipotent and reside at the base of intestinal crypts, responsible for regenerating the entire intestinal epithelium. Its high expression is a strong indicator of stemness. * **ASCL2 (Achaete-scute homolog 2):** A basic helix-loop-helix (bHLH) transcription factor that is a critical downstream effector of Wnt signaling and a key regulator of intestinal stem cell maintenance and proliferation. It is highly expressed in LGR5+ stem cells and is essential for their self-renewal and differentiation. * **TDGF1 (Teratocarcinoma-derived growth factor 1, also known as Cripto-1):** A member of the epidermal growth factor-CFC (EGF-CFC) family of proteins. It plays crucial roles in embryonic development, stem cell maintenance, and cancer. In the intestine, TDGF1 is expressed in crypt base columnar (CBC) cells, including LGR5+ stem cells, and is involved in Wnt and Nodal signaling pathways, supporting stem cell self-renewal. * **IGFBPL1 (Insulin-like growth factor binding protein-like 1):** While not as specific as LGR5 or ASCL2, IGFBPL1 has been implicated in cell growth, differentiation, and apoptosis. Its role in intestinal stem cells is less directly characterized but can be part of the broader regulatory network. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** A zinc transporter. Zinc homeostasis is crucial for cell proliferation and differentiation, and its expression can be associated with highly metabolic or proliferative cells, including stem cells. **Step 2. List the Key Cell Type Markers:** Based on the functional markers identified, the key cell type markers are: * **LGR5:** As discussed, this is the definitive marker for intestinal stem cells, specifically the crypt base columnar (CBC) cells. * **ASCL2:** A critical transcriptional regulator of LGR5+ intestinal stem cells, reinforcing the stem cell identity. * **TDGF1:** Another marker associated with intestinal crypt cells, including stem cells, supporting their proliferative and developmental roles. The presence of pseudogenes (e.g., RPL7P54, HMGN2P6, PPIAP40, EIF5AP4, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, PPIAP29, HNRNPA1P4, RPL9P21, PPIAP31, HMGN1P36, HMGN2P41, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, RPL7P6) is common in highly active transcriptional environments. While they don't directly define a cell type, their presence, particularly ribosomal protein pseudogenes (RPL, RPS), can sometimes correlate with high protein synthesis rates, characteristic of rapidly proliferating cells like stem cells. **Step 3. Cross-reference Known Databases:** * **LGR5:** Widely recognized as the gold standard marker for intestinal stem cells across numerous scRNA-seq datasets and bulk RNA-seq studies of intestinal crypts. Databases like Human Protein Atlas, GeneCards, and specific scRNA-seq atlases (e.g., Tabula Sapiens, Human Cell Atlas) consistently show high LGR5 expression in intestinal stem cell populations. * **ASCL2:** Also consistently found to be co-expressed with LGR5 in intestinal stem cells. Its role in Wnt signaling and stem cell maintenance is well-established in the literature (e.g., studies by Clevers lab, Barker lab). * **TDGF1:** While expressed in other contexts (e.g., embryonic stem cells, cancer), its expression in the intestinal crypt, particularly in CBC cells, is documented and supports a stem cell or progenitor identity. * **IGFBPL1 and SLC39A2:** Their expression in intestinal stem cells has been observed in some datasets, often reflecting metabolic or growth-related activities associated with these highly proliferative cells. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from the key markers, particularly the co-expression of **LGR5, ASCL2, and TDGF1**, the most probable general cell type is **Intestinal Stem Cells**. These markers are highly specific and define the multipotent, self-renewing population responsible for epithelial turnover in the large intestine. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong stem cell signature, we need to consider subtypes within the intestinal stem cell compartment or closely related progenitor populations. 1. **Most Likely: LGR5+ Crypt Base Columnar (CBC) Stem Cells:** * **Reasoning:** The presence of **LGR5** as a top marker is the strongest indicator. **ASCL2** and **TDGF1** further solidify this annotation, as they are critical regulators and markers of these specific stem cells located at the base of the intestinal crypts. These cells are highly proliferative and responsible for generating all other epithelial cell types. The presence of numerous pseudogenes, particularly ribosomal ones, is consistent with the high metabolic and protein synthesis demands of rapidly dividing cells. 2. **Second Most Likely: Early Intestinal Progenitor Cells (Transit-Amplifying Cells):** * **Reasoning:** While LGR5 is primarily a stem cell marker, some early progenitor cells (transit-amplifying or TA cells) that have recently divided from stem cells might still retain some residual LGR5 expression, along with high expression of proliferation-related genes. ASCL2 and TDGF1 also play roles in early differentiation. However, the *high* expression of LGR5 suggests a more direct stem cell identity rather than a purely TA cell. TA cells typically show a downregulation of LGR5 and an upregulation of lineage-specific markers as they commit to differentiation. Without other specific TA markers (e.g., high levels of proliferation markers like MKI67, PCNA, or early differentiation markers for specific lineages), it's less likely than pure LGR5+ stem cells. 3. **Third Most Likely: Secretory Progenitor Cells (e.g., immature Goblet/Paneth/Enteroendocrine cells):** * **Reasoning:** While LGR5+ cells are multipotent, they give rise to all lineages. Some early secretory progenitors might still express low levels of LGR5 or genes involved in stemness before fully committing to a secretory fate. However, this cluster lacks specific markers for mature secretory cells (e.g., MUC2 for Goblet, LYSOZYME for Paneth, CHGA for Enteroendocrine). The strong LGR5/ASCL2/TDGF1 signature points more towards the undifferentiated stem cell state rather than a committed progenitor. **Most Likely Subtype:** Based on the provided markers, the most likely subtype is **LGR5+ Crypt Base Columnar (CBC) Intestinal Stem Cells**. **6. Concise Summary of Your Analysis:** The analysis of the provided marker list strongly indicates the cell type is **Intestinal Stem Cells**, specifically **LGR5+ Crypt Base Columnar (CBC) cells** from the large intestine. The presence of **LGR5**, a canonical intestinal stem cell marker, alongside **ASCL2** and **TDGF1**, both critical regulators and markers of intestinal stem cell maintenance and proliferation, provides compelling evidence. The high expression of these genes, which are central to Wnt signaling and stem cell self-renewal, unequivocally points to this cell population. The numerous pseudogenes, particularly those related to ribosomal proteins, are consistent with the high metabolic and protein synthesis demands of rapidly dividing stem cells. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: { 'main_cell_type': 'Intestinal Stem Cells', 'sub_cell_types': [ 'LGR5+ Crypt Base Columnar (CBC) Stem Cells', 'Early Intestinal Progenitor Cells (Transit-Amplifying Cells)', 'Secretory Progenitor Cells (e.g., immature Goblet/Paneth/Enteroendocrine cells)' ], 'possible_mixed_cell_types': [], 'num_markers': 50 }"
intestinal enteroendocrine cell,Enteroendocrine Cells,"L-cells, Enterochromaffin (EC) cells, Multi-hormonal/Immature Enteroendocrine Cells","L-cells, Enterochromaffin (EC) cells",50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided ranked marker list from a human large intestine scRNA-seq dataset. **Step-by-Step Analysis:** **1. List the Key Functional Markers:** * **GCG (Glucagon):** A hormone primarily known for its role in glucose homeostasis, produced by alpha cells in the pancreas. However, GCG-expressing cells are also found in the intestine, where they can be involved in enteroendocrine functions. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** An enzyme involved in the proteolytic processing of prohormones and proneuropeptides into their mature, active forms. Essential for the production of many peptide hormones, including those found in enteroendocrine cells. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone (CRH) family. Expressed in various neuroendocrine cells, including a subset of enteroendocrine cells, and involved in stress responses and metabolic regulation. * **PYY (Peptide YY):** A peptide hormone secreted by L-cells in the gut in response to food intake. It plays a crucial role in regulating appetite, satiety, and gut motility. * **INSL5 (Insulin-like 5):** A peptide hormone primarily expressed in enteroendocrine L-cells, particularly in the colon and rectum. It's involved in gut motility and has been implicated in metabolic regulation. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells. It's a precursor to several biologically active peptides and is widely expressed in endocrine glands and neurons. * **SCG2 (Secretogranin II):** Another granin family member, often co-expressed with chromogranins in neuroendocrine cells. Involved in the packaging and secretion of peptide hormones. * **FEV (FEV Transcription Factor):** A transcription factor known to be involved in the development and differentiation of specific neuroendocrine cell types, including enteroendocrine cells. * **CPLX2 (Complexin 2):** A neuronal protein involved in synaptic vesicle exocytosis. Its presence in this context suggests a role in regulated secretion, characteristic of neuroendocrine cells. * **NKX2-2 (NK2 Homeobox 2):** A homeobox transcription factor critical for the development and differentiation of various neuroendocrine cell types, including pancreatic islet cells and a subset of enteroendocrine cells. * **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, involved in regulated exocytosis. * **SLC18A1 (Solute Carrier Family 18 Member A1, Vesicular Monoamine Transporter 1 - VMAT1):** Involved in the uptake of monoamines into synaptic vesicles. Its presence suggests the potential for monoamine synthesis and secretion, characteristic of some enteroendocrine cells (e.g., serotonin-producing cells). * **SCG3 (Secretogranin III):** Another granin family member, similar to CHGA and SCG2, indicating neuroendocrine identity. * **SCG5 (Secretogranin V):** Yet another granin, reinforcing the neuroendocrine phenotype. * **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin synthesis. Its presence strongly indicates the production of serotonin, a key neurotransmitter and hormone produced by enterochromaffin (EC) cells. * **INSM1 (Insulinoma-associated protein 1):** A transcription factor crucial for neuroendocrine differentiation and development. * **SNAP25 (Synaptosomal-Associated Protein, 25kDa):** A component of the SNARE complex, essential for vesicle fusion and neurotransmitter/hormone release. Its presence indicates active regulated secretion. * **CHGB (Chromogranin B):** Another member of the chromogranin family, further confirming neuroendocrine identity. * **RFX6 (Regulatory Factor X6):** A transcription factor essential for the development and differentiation of various endocrine cell types, including enteroendocrine cells. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel (KATP channel). KATP channels are critical for glucose-stimulated insulin secretion in pancreatic beta cells, and their presence in enteroendocrine cells can be linked to glucose sensing and hormone release. * **SCT (Secretin):** A peptide hormone secreted by S-cells in the duodenum in response to acidic chyme. While primarily duodenal, its presence suggests a broader enteroendocrine identity. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various cell types, including pancreatic alpha cells and some enteroendocrine cells. * **INA (Internexin Alpha):** An intermediate filament protein found in neurons and neuroendocrine cells. * **SLC5A8 (Solute Carrier Family 5 Member 8):** A sodium-coupled monocarboxylate transporter. Its role in enteroendocrine cells is less directly characterized as a primary functional marker, but it could be involved in nutrient sensing or transport. **Summary of Functional Markers:** The overwhelming presence of genes involved in hormone synthesis (GCG, PYY, INSL5, SCT, TPH1), processing (PCSK1), packaging (CHGA, SCG2, SCGN, SCG3, SCG5, CHGB), and regulated secretion (CPLX2, SNAP25, ABCC8), along with key neuroendocrine transcription factors (FEV, NKX2-2, INSM1, RFX6, ARX), strongly points towards a neuroendocrine cell type. **2. List the Key Cell Type Markers:** * **GCG, PYY, INSL5, SCT, TPH1:** These are specific peptide hormones or enzymes for hormone synthesis, directly indicating specific enteroendocrine cell subtypes (e.g., GCG for L-cells/A-like cells, PYY/INSL5 for L-cells, SCT for S-cells, TPH1 for EC cells). * **CHGA, SCG2, SCGN, SCG3, SCG5, CHGB:** General pan-neuroendocrine markers. * **PCSK1, FEV, NKX2-2, INSM1, RFX6, ARX:** Transcription factors critical for enteroendocrine cell development and differentiation. * **UCN3:** A marker for a specific subset of enteroendocrine cells, often co-expressed with other hormones. * **SLC18A1 (VMAT1):** Associated with monoamine-producing cells, such as enterochromaffin (EC) cells. * **ABCC8:** While known for pancreatic beta cells, its presence in enteroendocrine cells can indicate glucose-sensing capabilities. **Summary of Cell Type Markers:** The combination of general neuroendocrine markers (Chromogranins, Secretogranins), specific hormone genes (GCG, PYY, INSL5, SCT, TPH1), and key developmental transcription factors (FEV, NKX2-2, INSM1, RFX6, ARX) is highly characteristic of enteroendocrine cells. The presence of multiple specific hormone genes suggests a diverse population or a cell type capable of co-secreting multiple peptides. **3. Cross-reference Known Databases:** A rapid search of scRNA-seq atlases (e.g., Human Cell Atlas, Tabula Sapiens, specific gut scRNA-seq datasets) for these markers consistently identifies them as highly enriched in **enteroendocrine cells** within the intestinal epithelium. * **GCG, PYY, INSL5:** Classic markers for L-cells (colonic enteroendocrine cells). * **TPH1:** Classic marker for enterochromaffin (EC) cells (serotonin-producing). * **SCT:** Classic marker for S-cells (secretin-producing, primarily duodenum). * **CHGA, PCSK1, INSM1, RFX6, NKX2-2:** Pan-enteroendocrine and neuroendocrine developmental markers. * **UCN3:** Found in a subset of enteroendocrine cells, often co-expressed with PYY/GCG. The co-expression of these markers, especially the specific hormone genes, is a hallmark of enteroendocrine cell heterogeneity. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from the functional and cell type markers, the most probable general cell type is **Enteroendocrine Cells**. **Reasoning:** The presence of multiple peptide hormones (GCG, PYY, INSL5, SCT), enzymes for hormone processing (PCSK1), and synthesis (TPH1), along with universal neuroendocrine markers (CHGA, SCG2, SCGN, SCG3, SCG5, CHGB) and critical neuroendocrine transcription factors (FEV, NKX2-2, INSM1, RFX6, ARX), unequivocally points to an enteroendocrine lineage. These cells are specialized in sensing luminal contents and secreting hormones that regulate digestion, metabolism, and gut motility. **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the co-expression of multiple specific hormone markers, this cluster likely represents a heterogeneous population of enteroendocrine cells or a specific subtype with broad co-expression. 1. **Most Likely: L-cells (PYY/INSL5/GCG-positive enteroendocrine cells)** * **Reasoning:** PYY and INSL5 are highly specific and abundant markers for L-cells, which are the most prevalent enteroendocrine cell type in the colon (large intestine). GCG is also expressed in a subset of L-cells, often referred to as 'GLP-1/GCG-producing cells.' The high ranking of these markers strongly supports L-cell identity. UCN3 is also known to be expressed in a subset of L-cells. 2. **Second Most Likely: Enterochromaffin (EC) cells (TPH1/SLC18A1-positive enteroendocrine cells)** * **Reasoning:** TPH1 (Tryptophan Hydroxylase 1) is the rate-limiting enzyme for serotonin synthesis, making it a definitive marker for enterochromaffin (EC) cells. SLC18A1 (VMAT1) is also associated with monoamine transport in these cells. EC cells are the most numerous enteroendocrine cell type throughout the gut, including the large intestine. 3. **Third Most Likely: Multi-hormonal/Immature Enteroendocrine Cells or a specific subset with broad co-expression.** * **Reasoning:** The presence of SCT (secretin, typically S-cells in the duodenum) alongside colonic L-cell markers (PYY, INSL5, GCG) and EC cell markers (TPH1) suggests either: * A cluster containing multiple enteroendocrine subtypes. * Immature enteroendocrine cells that have not fully committed to a single hormone profile, or retain expression of progenitor markers. * A specific, less common enteroendocrine subtype that co-expresses a broader range of hormones, which has been observed in some studies, particularly in the context of plasticity or specific... [truncated]"
monocyte,Mixed Population of Enteric Nervous System Cells,"Myelinating Schwann Cells, Enteric Neurons, Non-Myelinating Enteric Glial Cells","Myelinating Schwann Cells, Enteric Neurons, Non-Myelinating Enteric Glial Cells",50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",2,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided ranked marker list from human large intestine tissue: **Step-by-Step Analysis:** **1. List the Key Functional Markers:** * **SPP1 (Osteopontin):** Involved in various biological processes including cell adhesion, migration, and immune responses. Often associated with tissue remodeling, inflammation, and cancer. In the context of the nervous system, it can play roles in neuronal survival and plasticity. * **PLP1 (Proteolipid Protein 1):** A major structural component of myelin in the central and peripheral nervous systems. Its presence is highly indicative of myelinating cells. * **L1CAM (L1 Cell Adhesion Molecule):** A neuronal cell adhesion molecule involved in neuron migration, axon guidance, and fasciculation. Crucial for nervous system development and function. * **NRXN1 (Neurexin 1):** Presynaptic cell adhesion molecule involved in synapse formation and function. Essential for proper neuronal communication. * **SOX10 (SRY-Box Transcription Factor 10):** A transcription factor critical for the development and maintenance of neural crest-derived cells, including Schwann cells, melanocytes, and enteric neurons/glia. Its expression is a strong indicator of neural crest lineage. * **SOX2 (SRY-Box Transcription Factor 2):** A transcription factor involved in maintaining pluripotency and self-renewal in stem cells, but also expressed in neural stem cells and some mature neural cell types. * **PTPRZ1 (Receptor-type Tyrosine-protein Phosphatase Zeta):** Expressed in the central nervous system, involved in neuronal development and glial cell differentiation. * **CDH2 (N-cadherin):** A classical cadherin involved in cell-cell adhesion, particularly prominent in neuronal synapses and neural development. * **ATP1A2 (Na+/K+ ATPase Subunit Alpha 2):** A subunit of the sodium-potassium pump, crucial for maintaining ion gradients across cell membranes, essential for neuronal excitability. * **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for GDNF family ligands, involved in the development and survival of various neuronal populations. * **FOXD3 (Forkhead Box D3):** A transcription factor involved in neural crest development and differentiation, similar to SOX10. **2. List the Key Cell Type Markers:** * **PLP1:** Strong marker for myelinating cells (oligodendrocytes in CNS, Schwann cells in PNS). * **L1CAM:** Neuronal and neural crest-derived cell marker. * **SOX10:** Definitive marker for neural crest derivatives, including Schwann cells and enteric glial cells. * **NRXN1, NRXN3:** Presynaptic adhesion molecules, indicative of neuronal cells. * **SYT10 (Synaptotagmin 10):** A synaptic vesicle protein, generally associated with neuronal cells. * **CHL1 (Cell Adhesion Molecule L1-like):** A neuronal cell adhesion molecule, related to L1CAM. * **FOXD3:** Neural crest marker. * **TUBB2B (Tubulin Beta 2B Class IIb):** A beta-tubulin isoform, highly expressed in neurons and involved in microtubule formation. * **KCNMB4 (Potassium Calcium-Activated Channel Subfamily M Beta 4):** A regulatory subunit of large conductance calcium-activated potassium channels, found in excitable cells like neurons. * **GJC3 (Gap Junction Protein Gamma 3):** A connexin, involved in gap junction formation, which can be found in various cell types including glial cells. * **RHAG (Rh Associated Glycoprotein):** While primarily known for red blood cells, it has been reported in some neuronal contexts. **3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) for these markers in the context of the large intestine reveals strong associations: * **PLP1, SOX10, L1CAM, NRXN1, FOXD3, TUBB2B:** These are consistently reported as markers for **enteric glial cells (EGCs)** and/or **enteric neurons** in the gastrointestinal tract. * **SPP1:** While broad, its co-expression with neural markers can indicate specific states or subtypes within the enteric nervous system (ENS), potentially related to neuroinflammation or tissue remodeling. * The high ranking of **PLP1** and **SOX10** together is particularly compelling for glial cells. **4. Determine the Most Probable General Cell Type:** The overwhelming presence and high expression of markers such as **PLP1, SOX10, L1CAM, NRXN1, SYT10, CDH2, TUBB2B, and FOXD3** strongly point towards cells of the **enteric nervous system (ENS)**. Specifically, the combination of myelin-related (PLP1) and neural crest/glial markers (SOX10, FOXD3) with neuronal markers (NRXN1, SYT10, L1CAM) suggests a mixed population or a cell type with both glial and neuronal characteristics, or a glial cell type that interacts intimately with neurons. Given the high ranking of PLP1 and SOX10, **glial cells** are highly probable. **5. Identify the Top 3 Most Probable Sub Cell Types:** Based on the markers, particularly the top-ranked ones: 1. **Enteric Glial Cells (EGCs):** This is the **most likely** subtype. * **Strong evidence:** **PLP1** (major myelin component, though EGCs are non-myelinating, PLP1 is expressed in some EGC subtypes and is a well-known marker for glial cells in the PNS), **SOX10** (definitive neural crest and EGC marker), **FOXD3** (neural crest/EGC marker), **L1CAM** (expressed by EGCs), **PTPRZ1** (expressed by glial cells). The high expression of PLP1, while typically associated with myelin, is also found in specific EGC populations, especially those with Schwann cell-like properties or developmental precursors. * **Reasoning:** EGCs are abundant in the large intestine and are neural crest-derived. They share many molecular features with Schwann cells and astrocytes, providing structural and metabolic support to enteric neurons, modulating synaptic transmission, and playing roles in gut homeostasis and pathology. The presence of both SOX10 and PLP1 is a hallmark of certain glial populations. 2. **Schwann Cells (Peripheral Myelinating/Non-myelinating):** * **Evidence:** **PLP1** (major myelin protein, highly expressed by myelinating Schwann cells), **SOX10** (definitive Schwann cell marker), **L1CAM**, **NRXN1**, **FOXD3**. * **Reasoning:** Schwann cells are the primary glial cells of the peripheral nervous system, which includes the ENS. While the large intestine's intrinsic ENS primarily contains EGCs, extrinsic innervation involves Schwann cells. The high expression of PLP1 makes this a strong candidate, especially if there's extrinsic nerve fiber contamination or a specific EGC subtype with Schwann cell-like characteristics. However, EGCs are generally considered the *intrinsic* glial cells of the gut. 3. **Enteric Neurons (specific subtypes):** * **Evidence:** **NRXN1, SYT10, L1CAM, CDH2, TUBB2B, ATP1A2, KCNMB4**. * **Reasoning:** While many neuronal markers are present, the *highest ranked* markers (NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10) lean more towards glial or neural crest-derived cells. If it were purely neuronal, we might expect more classical pan-neuronal markers (e.g., NEUROD1, RBFOX3/NeuN, SYP) to be higher. However, the presence of NRXN1 and SYT10 indicates a strong neuronal component or close association. It's possible this cluster represents a mixed population of neurons and glia, or a specific neuronal subtype that expresses some of these glial-associated markers. Given the top markers, it's less likely to be *purely* neuronal. **Most Likely Subtype:** Based on the strong and high-ranking expression of **PLP1, SOX10, and FOXD3**, the most likely cell type is **Enteric Glial Cells (EGCs)**. The presence of neuronal markers suggests either a close association (e.g., EGCs surrounding neurons) or a specific EGC subtype that shares some gene expression with neurons, or even a small contamination of neurons within the cluster. However, the glial signature is dominant. **6. Concise Summary of Your Analysis:** The provided marker list from human large intestine tissue strongly indicates the presence of **Enteric Glial Cells (EGCs)**. Key markers such as **PLP1, SOX10, and FOXD3**, all highly ranked, are definitive for neural crest-derived glial populations in the peripheral nervous system, including the gut. While neuronal markers like NRXN1 and SYT10 are also present, their ranking relative to the prominent glial markers suggests that EGCs are the primary cell type in this cluster. The co-expression of SPP1 might indicate a specific functional state or subtype of EGCs, possibly involved in neuroinflammation or tissue remodeling within the enteric nervous system. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION FAILED Feedback: The analysis correctly identifies many key markers and their relevance to the enteric nervous system. However, there are several critical issues that lead to a 'FAILED' validation: 1. **Marker Consistency and Ranking Discrepancy:** * The 'Key Functional Markers' and 'Key Cell Type Markers' sections list markers (e.g., PLP1, L1CAM, NRXN1, SOX10, SOX2, PTPRZ1, CDH2, ATP1A2, GFRA2, FOXD3, SYT10, CHL1, TUBB2B, KCNMB4, GJC3, RHAG) and discuss their significance. * However, the provided 'Marker List' (NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2) is a *ranked list*. The analysis *does not consistently use this ranking* when discussing the most important markers. * For example, the analysis states: 'The high ranking of PLP1 and SOX10 together is particularly compelling for glial cells.' While PLP1 and SOX10 are indeed present in the top 15, the *highest ranked* marker is NKAIN3, follo... [truncated]"
plasma cell,B Lymphocyte Lineage,"Plasma Cells, Plasmablasts, Memory B Cells","MYL2, BFSP2",50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed, step-by-step analysis to identify the cell type based on the provided marker list: **1. List the Key Functional Markers:** * **Immunoglobulin Genes (IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2):** These are the most prominent markers in the list. They represent various components of immunoglobulins (antibodies): * **IGLL5, IGLV6-57, IGLC3, IGLC2, IGLV3-1, IGLV2-11:** Immunoglobulin lambda light chain variable and constant regions, and lambda-like polypeptide 5. * **IGHV3-7, IGHG1, IGHV3-23, IGHG3, IGHM, IGHA1, IGHA2:** Immunoglobulin heavy chain variable, gamma (IgG1, IgG3), mu (IgM), and alpha (IgA1, IgA2) constant regions. * **IGKC, IGKV4-1, IGKV1-5, IGKV3-20:** Immunoglobulin kappa light chain constant and variable regions. * **JCHAIN:** Joining chain, a polypeptide that links monomeric immunoglobulin units (e.g., in dimeric IgA or pentameric IgM). * **Functional Role:** The extensive expression of immunoglobulin heavy and light chain genes, along with the J-chain, is the hallmark of antibody production. This strongly points towards cells involved in humoral immunity. * **TNFRSF17 (BCMA - B-cell maturation antigen):** A receptor for BAFF and APRIL, crucial for plasma cell survival and differentiation. Its presence indicates a mature B-cell lineage, specifically those differentiating towards or already in a plasma cell state. * **MZB1 (Marginal Zone B and B1 Cell Specific Protein):** While its name suggests marginal zone B cells, MZB1 is also highly expressed in plasma cells and is involved in immunoglobulin assembly and secretion. * **GPRC5D (G protein-coupled receptor class C group 5 member D):** Expressed on plasma cells and is a target for some multiple myeloma therapies. Its presence supports a plasma cell identity. * **FCRL5 (Fc Receptor Like 5):** An inhibitory Fc receptor expressed on B cells and plasma cells, particularly those involved in immune regulation or memory. * **DERL3 (Derlin 3):** Involved in endoplasmic reticulum-associated degradation (ERAD), which is highly active in cells with extensive protein synthesis and secretion, such as plasma cells producing large amounts of antibodies. * **TXNDC5 (Thioredoxin Domain Containing 5):** Another ER-resident protein involved in protein folding and disulfide bond formation, consistent with high antibody production. * **CCL3 (MIP-1α - Macrophage Inflammatory Protein-1 alpha):** A chemokine that can be produced by various immune cells, including plasma cells, and is involved in inflammation and immune cell recruitment. * **BMP6 (Bone Morphogenetic Protein 6):** While broadly expressed, it can play roles in immune regulation and tissue homeostasis. Its presence here might be context-dependent but less specific than the immunoglobulin genes. * **APOBEC3A (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-like 3A):** An enzyme involved in innate immunity, particularly against retroviruses, and can be expressed in various immune cells. Its role in plasma cells is less direct but could be related to immune responses. **2. List the Key Cell Type Markers:** Based on the functional markers, the key cell type markers are overwhelmingly indicative of the B cell lineage, specifically terminally differentiated B cells. * **Immunoglobulin Genes (IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2):** These are *the* defining markers for antibody-producing cells. The co-expression of heavy chain constant regions (IgG, IgA, IgM) suggests isotype switching, a characteristic of mature B cells differentiating into plasma cells. * **TNFRSF17 (BCMA):** A canonical marker for plasma cells and late-stage B cells. * **MZB1:** Highly expressed in plasma cells. * **GPRC5D:** A plasma cell-specific surface marker. * **FCRL5:** Expressed on B cells and plasma cells. *Less specific/contextual markers:* * **MYL2 (Myosin Light Chain 2):** Primarily associated with muscle cells, its presence here is unusual for a typical immune cell. It might indicate a rare subpopulation, contamination, or a novel finding. However, given the overwhelming immunoglobulin signature, it's likely a minor or non-specific signal in this context. * **ANKRD36BP2, AMPD1, DERL3, TXNDC5, UBE2QL1, DNAAF1, CXorf21:** These are more general cellular process genes (e.g., protein folding, metabolism, ubiquitination) that might be upregulated in highly active cells like plasma cells, but are not specific cell type markers on their own. * **LINC/AC/AL/RNU/AP/U/AC/AL/LINC/AC/LINC/AC/APO/AC:** A large number of long intergenic non-coding RNAs (lincRNAs) and uncharacterized transcripts. These can be cell-type specific but require further investigation and are not immediately informative without prior knowledge. * **CCR10 (C-C Motif Chemokine Receptor 10):** Expressed on various immune cells, including some B cells and plasma cells, involved in homing to specific tissues like the gut. * **BFSP2 (Beaded Filament Structural Protein 2):** Primarily associated with lens fiber cells, its presence is highly unusual and likely represents a very minor contaminant or a spurious signal. **3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, Azimuth/Seurat reference datasets for intestine) for the top markers confirms their association: * **IG genes (IGHG1, IGHA1, IGHM, IGLC, IGKC, JCHAIN):** Universally recognized as plasma cell markers. The presence of multiple isotypes (IgG, IgA, IgM) indicates mature, class-switched plasma cells. * **TNFRSF17 (BCMA):** A well-established plasma cell marker. * **MZB1:** Confirmed as a plasma cell marker, involved in antibody secretion. * **GPRC5D:** Increasingly recognized as a plasma cell marker, particularly in the context of multiple myeloma. * **FCRL5:** Found on B cells and plasma cells. * **DERL3, TXNDC5:** Often co-expressed in cells with high ER stress and protein production, consistent with plasma cells. The presence of MYL2 and BFSP2 is anomalous and would typically be flagged for further investigation (e.g., potential doublet, contamination, or a very rare, uncharacterized cell state). However, given the overwhelming signal from the immunoglobulin and plasma cell-specific genes, these are likely minor noise. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming expression of immunoglobulin genes (heavy and light chains, multiple isotypes, JCHAIN), TNFRSF17 (BCMA), MZB1, GPRC5D, and ER-related genes (DERL3, TXNDC5), the most probable general cell type is **B Lymphocyte Lineage**, specifically terminally differentiated antibody-secreting cells. **5. Identify the Top 3 Most Probable Sub Cell Types:** 1. **Plasma Cells:** This is by far the most likely subtype. The extensive and diverse immunoglobulin gene expression (IGHG1, IGHA1, IGHM, IGLC, IGKC, JCHAIN), coupled with canonical plasma cell markers like TNFRSF17 (BCMA), MZB1, and GPRC5D, is a definitive signature of plasma cells. The presence of multiple heavy chain isotypes (IgG, IgA, IgM) further suggests a mature, class-switched plasma cell population. The high expression of ER-related genes (DERL3, TXNDC5) is also consistent with the massive protein synthesis (antibody production) occurring in plasma cells. Given this is large intestine tissue, IgA-secreting plasma cells are particularly abundant and crucial for mucosal immunity. 2. **Plasmablasts:** These are immediate precursors to plasma cells, characterized by high immunoglobulin production and expression of some plasma cell markers, but they retain some proliferative capacity and may still express some B cell markers (though fewer than naive B cells). While the markers are highly indicative of full plasma cells, plasmablasts represent a very close developmental stage. However, the strong presence of *multiple* constant region genes (IGHG1, IGHA1, IGHM) and the high expression of *terminal* differentiation markers like TNFRSF17 lean more towards fully differentiated plasma cells. 3. **Memory B Cells (activated/differentiating):** While memory B cells can express class-switched immunoglobulins (like IgG or IgA) and can rapidly differentiate into plasma cells upon re-stimulation, they typically do not show the same high level of *secreted* immunoglobulin gene expression, nor the strong upregulation of ER-related genes or the full suite of plasma cell-specific surface markers (like GPRC5D or high BCMA). The provided list strongly points to active antibody secretion, which is the primary function of plasma cells. **Most Likely Subtype:** The most likely subtype is **Plasma Cells**. The combination of comprehensive immunoglobulin gene expression (including multiple isotypes and JCHAIN), strong expression of TNFRSF17 (BCMA), MZB1, and GPRC5D, along with ER-associated genes, unequivocally points to terminally differentiated, antibody-secreting plasma cells. The tissue context (large intestine) further supports this, as the gut is rich in plasma cells, particularly IgA-secreting ones, crucial for mucosal immunity. **6. Provide a Concise Summary of Your Analysis:** This cell cluster is definitively identified as **Plasma Cells**. The annotation is driven by the overwhelming expression of various immunoglobulin heavy and light chain genes (e.g., *IGHG1, IGHA1, IGHM, IGLC3, IGKC, JCHAIN*), indicating active antibody synthesis and secretion, including class-switched isotypes. Key plasma cell-specific markers such as *TNFRSF17 (BCMA)*, *MZB1*, and *GPRC5D* are highly expressed, confirming their terminally differentiated state. Additionally, the presence of ER-associated genes like *DERL3* and *TXNDC5* is consistent with the extensive protein production characteristic of plasma cells. The tissue origin (large intestine) further supports the presence of th... [truncated]"
transit amplifying cell of large intestine,Proliferating Cells,"Intestinal Stem Cells (ISCs), Transit-Amplifying (TA) Cells, Proliferating Immune Cells","Intestinal Stem Cells (ISCs), Transit-Amplifying (TA) Cells",50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: This is an excellent task. I will proceed with a comprehensive, step-by-step analysis to identify the cell type based on the provided ranked marker list from a human large intestine tissue scRNA-seq dataset. ### Step-by-Step Analysis: #### 1. List the Key Functional Markers: The provided list is overwhelmingly enriched with genes involved in cell cycle progression, DNA replication, and mitosis. * **Cell Cycle Progression & Mitosis:** * **UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2.** * **Roles:** * **MKI67 (Ki-67):** A classic and widely used marker for cell proliferation. Its presence is a strong indicator of actively dividing cells. * **TOP2A (DNA Topoisomerase II Alpha):** Essential for DNA replication and chromosome segregation during mitosis. * **RRM2 (Ribonucleotide Reductase M2):** Catalyzes the rate-limiting step in dNTP synthesis, crucial for DNA replication. * **CDK1 (Cyclin-Dependent Kinase 1):** A key regulator of cell cycle progression, particularly G2/M transition. * **CCNB2 (Cyclin B2) & CCNA2 (Cyclin A2):** Cyclins are regulatory proteins that activate CDKs, driving cell cycle progression. Cyclin B is critical for mitotic entry. * **AURKB (Aurora Kinase B):** A serine/threonine kinase crucial for chromosome segregation and cytokinesis. * **BIRC5 (Survivin):** An anti-apoptotic protein highly expressed in proliferating cells, involved in chromosome segregation and cytokinesis. * **KIF2C, KIF15, KIF18B (Kinesin Family Members):** Motor proteins involved in spindle formation and chromosome movement during mitosis. * **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, essential for kinetochore assembly and chromosome segregation. * **PBK (PDZ Binding Kinase):** Involved in cell cycle progression and mitosis. * **PLK1 (Polo-like Kinase 1):** A key regulator of multiple mitotic events, including centrosome maturation, spindle assembly, and cytokinesis. * **FOXM1 (Forkhead Box M1):** A transcription factor that regulates the expression of numerous genes involved in cell cycle progression and mitosis. * **CDC45, CDT1, GINS2, TK1, POLQ:** Involved in DNA replication initiation and elongation. * **ASPM, CEP55, DLGAP5, SPC24, SPC25, SKA1, SKA3, NUF2, NCAPG, OIP5, TTK, NEK2, CDC25C:** All are highly associated with various aspects of mitosis, including spindle assembly, chromosome condensation, and cytokinesis. * **General Functional Role:** The overwhelming presence of these markers indicates a highly proliferative state, characteristic of cells undergoing rapid division. #### 2. List the Key Cell Type Markers: Based on the provided list, there are no specific markers for differentiated, mature cell types (e.g., specific epithelial cells, immune cells, stromal cells, or neuronal cells). Instead, the markers are almost exclusively related to cell cycle and proliferation. * **No specific terminally differentiated cell type markers are present.** * **The markers are universal indicators of cell division.** #### 3. Cross-reference Known Databases: * Searching databases like Human Protein Atlas, GeneCards, and literature for these genes (e.g., MKI67, TOP2A, RRM2, CDK1, CCNB2, AURKB, PLK1, FOXM1) consistently points to their roles in cell cycle, DNA replication, and mitosis. * In the context of single-cell RNA sequencing, a cluster highly enriched for these genes is universally annotated as 'proliferating cells' or 'cycling cells.' * In the large intestine, the primary source of proliferating cells is the intestinal crypts, where stem cells and transit-amplifying (TA) cells reside. #### 4. Determine the Most Probable General Cell Type: Based on the exclusive and high expression of cell cycle and proliferation-associated genes, the most probable general cell type is **Proliferating Cells** or **Cycling Cells**. #### 5. Identify the Top 3 Most Probable Sub Cell Types: Given the tissue context (large intestine) and the strong proliferative signature, the sub-cell types would be those actively dividing within the intestinal epithelium. 1. **Intestinal Stem Cells (ISCs):** These are the primary self-renewing cells at the base of the crypts responsible for maintaining the intestinal epithelium. They are highly proliferative and express many of these cell cycle markers. 2. **Transit-Amplifying (TA) Cells:** These cells are progeny of ISCs and undergo rapid proliferation as they migrate up the crypt-villus axis, amplifying the cell number before differentiation. They are also highly proliferative and would express these markers. 3. **Proliferating Immune Cells (e.g., Lymphocytes, Macrophages):** While less likely to be the *primary* component of such a strong and uniform proliferative signature in a tissue context (unless there's an inflammatory state), immune cells can proliferate. However, their specific markers (e.g., CD3, CD19, CD68) are absent from the list, making them a less probable *dominant* component for this specific cluster. **Most Likely Subtype:** Given the context of the large intestine and the robust, broad set of proliferation markers, the most likely subtype is a combination of **Intestinal Stem Cells (ISCs) and Transit-Amplifying (TA) Cells**. These two populations are the main drivers of epithelial renewal and are characterized by high expression of these cell cycle genes. It's often difficult to definitively separate ISCs from early TA cells based solely on pan-proliferation markers, as both are highly proliferative. However, the presence of such a comprehensive set of mitotic genes suggests a population actively undergoing cell division. #### 6. Provide a Concise Summary of Your Analysis: This cell cluster from the human large intestine is unequivocally identified as **Proliferating Cells**. The marker list is overwhelmingly dominated by genes critical for various stages of the cell cycle, DNA replication, and mitosis (e.g., MKI67, TOP2A, RRM2, CDK1, CCNB2, AURKB, PLK1, FOXM1). This robust proliferative signature, in the context of intestinal tissue, strongly indicates that these cells are actively dividing. The most probable specific cell types contributing to this cluster are **Intestinal Stem Cells (ISCs)** and **Transit-Amplifying (TA) Cells**, which are responsible for the continuous renewal of the intestinal epithelium. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: { 'main_cell_type': 'Proliferating Cells', 'sub_cell_types': [ 'Intestinal Stem Cells (ISCs)', 'Transit-Amplifying (TA) Cells', 'Proliferating Immune Cells' ], 'possible_mixed_cell_types': [ 'Intestinal Stem Cells (ISCs)', 'Transit-Amplifying (TA) Cells' ], 'num_markers': 50 }"
